figshare
Browse
retraction request.png (1.17 MB)

@NEJM @Boehringer RE-LY (#Pradaxa dabigatran) retraction #AllTrials (2nd request)

Download (0 kB)
Version 3 2014-08-19, 05:35
Version 2 2014-08-19, 05:35
Version 1 2014-08-17, 10:10
figure
posted on 2014-08-19, 05:35 authored by Jorge H RamirezJorge H Ramirez

NEJM & Boehringer: request to retract a publication of the RE-LY study (dabigatran – Pradaxa) – July 29, 2014

For more information follow this URL & scrutinize Twitter messages.

https://twitter.com/search?f=realtime&q=%40boehringeruk%20%40jorgehernnramre&src=typd

ResearchGate DOI: 10.13140/2.1.2828.9927

History

Usage metrics

    Categories

    Keywords

    PradaxaPharmacology

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC